EUVIMED · CrossrefZeitschrift
Current Atherosclerosis Reports
ISSN 1523-3804 · Springer Science and Business Media LLC
Neueste Artikel
Bridging the Gap: How Accounting for Social Determinants of Health Can Improve Digital Health Equity in Cardiovascular Medicine
Lp(a): A Rapidly Evolving Therapeutic Landscape
Statin Use in Children and Adolescents – Dos, Don’ts and Practical Tips
The Emerging Potential of Apolipoprotein C-III Inhibition for ASCVD Prevention: A State-of-the-Art Review
IL-6 and Cardiovascular Risk: A Narrative Review
Inflammation in the Peri-ACS Period: Ready for Prime Time?
Statin therapy in primary and secondary cardiovascular disease prevention
Debate: Lipid-lowering Therapies and Diabetes Development
Inclisiran, Reasons for a Novel Agent in a Crowded Therapeutic Field
Pregnancy Complications and Long-Term Atherosclerotic Cardiovascular Disease Risk
Lipid Lowering Therapy Utilization and Lipid Goal Attainment in Women
Inflammation-Driven Plaque Erosion in Atherosclerosis: A Focus on Complement System Pathways
Achieving More Optimal Lipid Control with Non-Statin Lipid Lowering Therapy
The Role of Non-Statin Lipid Lowering Therapies to Reduce ASCVD Events in Primary Prevention
Remnant Cholesterol: Should it be a Target for Prevention of ASCVD?
Managing Dyslipidemia in Chronic Kidney Disease: Implications for Cardiovascular and Renal Risk
The Atherosclerotic Plaque Microenvironment as a Therapeutic Target
Role of Aspirin in Reducing Risk for Atherosclerotic Cardiovascular Disease in Individuals with Elevated Lipoprotein(a)
Circular RNA role in Atherosclerosis Development and Progression
ApoC-III as Therapeutic Target: Is it Primetime for Clinical Use?
Recent Progress of Sterol Regulatory Element-binding Proteins Role in Atherosclerosis
Cholesterol Crystals as Triggers of NLRP3 Inflammasome Activation in Atherosclerosis
Unveiling the Sex-Based Divide: Exploring Sex Differences in Peripheral Artery Disease
Cardiovascular Risk Associated with Menopause and Menopause Hormone Therapy: A Review and Contemporary Approach to Risk Assessment
Effects of Pioglitazone On Lipoprotein(a): A Meta-analysis
Serial Coronary CTA for Monitoring Response to Lipid-Lowering Therapy: A Narrative Review
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2025 European Society of Cardiology Conference
AI in Adipose Imaging: Revolutionizing Visceral Adipose Tissue, Ectopic Fat, and Cardiovascular Risk Assessment
Review of OxLDL Driven Inflammatory Cell Activation
HIV and Cardiovascular Disease Burden in Young Adults (18–25 years): A Review of Current Evidence
EUVIMED